Kathleen Moore to Sulfonamides
This is a "connection" page, showing publications Kathleen Moore has written about Sulfonamides.
Connection Strength
0.351
-
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016. Gynecol Oncol. 2024 07; 186:61-68.
Score: 0.212
-
Management of the toxicities of common targeted therapeutics for gynecologic cancers. Gynecol Oncol. 2018 03; 148(3):591-600.
Score: 0.138